Home » Healthcare » Infectious Disease Therapeutics Market

Infectious Disease Therapeutics Market By Disease Type (Antibiotics, Antivirals, Antifungals, Antiparasitics, Vaccines) By Route of Administration (Oral Drugs (Intravenous (IV) Drugs, Topical Drugs, Inhalable Drugs, Injectable Drugs)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Executive Summary

Market Overview

The global Infectious Disease Therapeutics Market has been steadily growing in recent years and is predicted to grow at a 5.00% CAGR between 2023 and 2030. The market is anticipated to be worth USD 171157.1 million by 2030, up from USD 115845.9 million in 2022.

A rapidly growing area of the pharmaceutical and healthcare sectors is the infectious disease therapeutics market. It consists of a broad spectrum of medications and therapies intended to treat infectious diseases brought on by bacteria, viruses, fungi, and parasites. The market is being driven by a number of factors, including an increase in the frequency of diseases, advancements in medical technology, and greater public awareness of the need of early diagnosis and treatment.

One of the key factors in the market’s growth is the rising prevalence of infectious illnesses throughout the world. The spread of infectious illnesses is facilitated by factors such as population growth, urbanization, and globalization, which raises the need for efficient medications.

Furthermore, the rise of drug-resistant infections has underlined the need for novel, focused treatments.

However, there are some constraints in the market. The high expense of researching and producing new therapies, tight regulatory constraints, and the complexity of addressing a varied variety of infectious diseases with varying treatment regimens are among these.

Despite these obstacles, the sector offers numerous opportunities. Biotechnology and genetic advances have opened up new avenues for generating tailored and precise medicines. Furthermore, increased R&D spending, as well as cooperation between pharmaceutical corporations and academic institutions, are pushing innovation in the industry.

Market Definition

The Infectious Disease Therapeutics Market is the industry and market for medications and therapies intended specifically to battle infectious diseases. It refers to a wide range of pharmacological agents and therapies designed to prevent, treat, or manage infectious disorders caused by bacteria, viruses, fungus, or parasites. Antibiotics, antivirals, antifungals, antiparasitics, and vaccinations are among the therapeutic alternatives available in the market. By providing effective treatment options to patients and contributing to public health efforts, the Infectious Disease Therapeutics Market plays a critical role in alleviating the global burden of infectious illnesses.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The global demand for Infectious Disease Therapeutics was valued at USD 115845.9 million in 2022 and is expected to reach USD 171157.1 Million in 2030, growing at a CAGR of 5.00% between 2023 and 2030.

Vaccines are the most rapidly rising segment of the Infectious Disease market. The therapeutics market, as well as the antifungal and antiviral categories, are expected to account for a major portion.
The market for oral drugs has emerged as the fastest growing, with injectable drugs being another key category in the market.
The bacterial infection category has emerged as the fastest growing market, and the categories are expected to gain traction during the forecast period as viral and fungal infections become more common.
The hospital segment had the biggest revenue share of 54.5% in 2022, and the clinics segment is predicted to grow at the fastest CAGR.
Vaccines have a monopoly on the market. Vaccines play a crucial role, and Branded drug is predicted to expand at the fastest rate.
Respiratory Infections is the fastest growing sector, while Vector-Borne Diseases is another significant segment in the Infectious Disease Therapeutics Market.
Marketed Products has the biggest market demand, and Late-stage is the second largest stakeholder group in the Infectious Disease Therapeutics Market.
North America was the market leader in 2022, accounting for 39.9% of total revenue, while Asia Pacific is expected to grow at the quickest CAGR over the projected period.
Government initiatives drive market growth.
The high cost of treatment is expected to limit market growth.

Segmentation by Disease Type

The therapeutics market for infectious diseases has vaccines as its fastest-growing subsegment. Because they are effective at preventing infectious illnesses, vaccines are becoming more and more popular. Vaccines help the immune system identify and fight off certain viruses, providing long-term protection from a number of infectious illnesses.

During the forecast period, the antifungal and antiviral categories are also likely to account for a significant proportion of the global market.

Segmentation by Route of Administration

Due to its greatest part in the global economy, the market for oral drugs has emerged as the one with the quickest growth. The market’s rising need for cutting-edge medications has helped this sector generate a sizable amount of money over time, and it is anticipated that this trend will continue into the future.
During the projected period, the injectable drugs another important category in the market.

Segmentation by Targeted Pathogens

The bacterial infection category has emerged as the fastest growing market over time and is likely to exhibit a significant increase in the future. The rising research and development activities done by leading market players in order to create innovative, technologically sophisticated medicines has helped the bacterial infection segment to grow significantly over time.
The segments are likely to gain traction during the projection period as viral and fungal illnesses grow more widespread.

Segmentation by End-Users

In 2022, the hospital segment had the highest revenue share of 54.5%. A significant growing factor for the market is the increasing frequency of emergency hospital visits reporting infectious illnesses.
During the projection period, the clinics segment is expected to develop at the quickest CAGR.

Segmentation by Product Type

Vaccines dominate the market. Vaccines serve an important role in the prevention of infectious diseases by activating the immune system to create an immunological response against certain microorganisms.
Branded drug are expected to grow at the quickest rate between 2023 and 2030.

Segmentation by Infection Disease Indication

Respiratory Infections is the fastest increasing sector. Pneumonia, influenza, bronchitis, and tuberculosis are examples of respiratory infections. These infections are widespread around the world and can have serious health consequences.
Vector-Borne Diseases are another major area in the Infectious Disease Therapeutics Market.

Segmentation by Research and Development Stage

Marketed Products is the segment having the highest market demand. Marketed products are treatments that have already been approved by regulatory bodies and are available for purchase on the market.
The Late-stage segment is the second largest stakeholder category in the Infectious Disease Therapeutics Market.

Segmentation by Region

In 2022, North America dominated the market, accounting for 39.9% of total revenue.
Asia Pacific is predicted to grow at the fastest CAGR during the projection period.
The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Infectious Disease Therapeutics.

North America dominated the market in 2022,. The rising prevalence of such conditions, together with favourable reimbursement scenarios, are projected to drive demand for infectious disease medicines in the region. Furthermore, the presence of many manufacturers in the United States, as well as an increasing number of clinical studies for generating new treatment medications, are projected to contribute to this region’s substantial market share. This market is expected to grow as a result of increased financing initiatives to promote the development of innovative medicines, rising rates of treatment and diagnosis of infectious illnesses, and other factors. The Centres for Disease Control and Prevention report that influenza and pneumonia contributed to 41,917 fatalities in the US.

During the forecast period, Asia Pacific is expected to develop at the quickest CAGR. The high prevalence of HIV, malaria, tuberculosis, and other infections; the increasing frequency of these ailments; and increased expenditure on infectious disease prevention and diagnostics are projected to be the driving forces behind the market’s expansion. Furthermore, rising government focus on infection prevention and collecting funding to enhance the adoption of infectious illness treatments are likely to propel the market throughout the forecast period.

Key Highlights of the Report

The global Infectious Disease Therapeutics Market is segmented by Disease Type, Route of Administration, Targeted pathogens, End-User, Product Type, Infectious disease Indication, Research and Development Stage and region. The hospital segment had the biggest revenue share of 54.5% in 2022. The bacterial infection and vaccines segment has emerged as the market’s fastest expanding. In addition, the clinics category is predicted to grow at the fastest CAGR, while Marketed Products has the largest market demand, with North America leading the market growth.

The primary drivers of the market are the increasing frequency of infectious diseases worldwide, advancements in medical technology and treatment options, and growing awareness about the need of early diagnosis and treatment. Furthermore, the market faces hurdles such as the high cost of discovering and producing new medicines, stringent regulatory standards and approval processes, and the complexity of addressing a varied variety of infectious diseases with varying treatment modalities.

Nonetheless, in 2022, North America led the market. The increased prevalence of such diseases, combined with attractive reimbursement circumstances, is expected to drive demand for infectious disease drugs in the region. Furthermore, Asia Pacific is predicted to grow at the fastest CAGR during the projection period.

What Factors Are Fueling The Growth Of The Global Infectious Disease Therapeutics Market?

Infectious diseases several variables influence the therapeutics market. Infectious infections are becoming more common all around the world. The spread of infectious diseases has become more prevalent as a result of variables such as population expansion, urbanization, and globalization, producing a higher demand for efficient therapies. Medical technology and treatment choices advancements have contributed to the market’s growth. These breakthroughs have allowed for the creation of novel treatments that target specific pathogens and enhance patient outcomes.

What Are The Key Challenges Encountered By The Global Infectious Disease Therapeutics Market?

Despite its promising growth possibilities, the Infectious Disease Therapeutics Market is not without its challenges. A hurdle is the high expense of researching and manufacturing novel treatments. Extensive research and clinical studies are necessary, which are expensive. Furthermore, market participants confront additional obstacles as a result of onerous regulatory requirements and licensing processes. Regulation compliance and gaining essential approvals can be time-consuming and costly.

What Opportunities For Growth Exist In The Global Infectious Disease Therapeutics Market?

The Infectious Disease Therapeutics Market offers numerous potential for expansion and innovation. Biotechnology and genetic advances have created new opportunities for personalized and precision medicines. Tailored treatments for better outcomes can be devised with a better understanding of the genetic composition of infections and patients. Increasing investments in research and development are promoting field innovation. Pharmaceutical corporations and academic institutions are working together to develop new treatment techniques and treatments.

Market Drivers

The global Infectious Disease Therapeutics Market is driven by several factors. The following are the key drivers of the global Infectious Disease Therapeutics Market:

Increased Illness Prevalence Among People

The rising frequency of diseases among individuals is a major driver in the Infectious Disease Therapeutics Market. As diseases proliferate and affect greater populations, there is a rising need for better medicines to battle these infections and improve patient outcomes. Infectious diseases are on the rise due to factors such as population expansion, urbanization, international travel, and climate change. The global healthcare industry is experiencing an increase in demand for novel therapies that can effectively target and treat chronic disorders.

Pharmaceutical companies and healthcare providers are investing in research and development to provide novel cures and treatments to meet the growing burden of infectious diseases. These improvements aim to give patients with improved treatment options, prevent the spread of illnesses, and, eventually, save lives.

Government Initiatives

Governments all across the world are adopting proactive measures to tackle infectious diseases through a variety of initiatives. These activities include funding programs for research and development, public awareness campaigns, and the establishment of healthcare infrastructure to promote illness prevention and treatment. Furthermore, governments and pharmaceutical corporations are working to hasten the research and dissemination of beneficial medications. These projects seek to improve treatment access, strengthen healthcare systems, and reduce the impact of infectious diseases on public health. Governments are actively contributing to the growth and improvement of the Infectious Disease Therapeutics Market by spending in research, education, and infrastructure, ultimately leading to improved outcomes for patients and communities globally.

Market Restraints

The global Infectious Disease Therapeutics Market faces some challenges that may hinder its growth. These include the following:

High Price of Treatment is Expected to Restrain Market Growth

The costs of creating and producing medications, performing clinical studies, and securing regulatory approvals all contribute to the overall therapy cost. These expenses are subsequently passed on to patients, making access to effective therapies difficult, particularly for those with poor financial resources. The high expense of therapy can also put a burden on healthcare systems and insurance companies, resulting in affordability and coverage concerns. This constraint might lead to delayed or insufficient treatment for infectious diseases, negatively compromising patient outcomes and public health. Efforts are being made to solve this issue through measures such as price negotiations, the availability of generic drugs, and healthcare reforms. Finding a balance between maintaining cheap access to therapy and supporting innovation in the Infectious Disease Therapeutics Market, on the other hand, remains a difficult challenge.

Opportunities

The global Infectious Disease Therapeutics Market offers significant growth opportunities. These include the following:

Increasing Acceptance Of Advanced Treatment Methods

There is a growing desire for sophisticated therapeutic alternatives that can effectively tackle infectious diseases as people become more open to innovative and cutting-edge remedies. Factors driving this acceptance include advances in medical technology, improved understanding of the benefits of sophisticated treatments, and a desire for more targeted and individualized remedies. Advanced treatment methods offer the potential to increase efficacy, lessen adverse effects, and enhance patient outcomes. Examples include gene therapy, immunotherapy, and precision medicine. This opportunity benefits patients not just by giving more effective treatment options, but it also fosters growth and innovation in the Infectious Disease Therapeutics Market.

Pharmaceutical businesses and healthcare providers are investing in R&D to capitalize on this potential and address patients’ changing requirements in the fight against infectious diseases.

Competitive Landscape

Key Players

The global Infectious Disease Therapeutics Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Pfizer Inc. (U.S.)
GlaxoSmithKline plc. (U.K)
Merck & Co. (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
AstraZeneca (U.K)
Mylan N.V. (U.S.)
Novartis AG (Switzerland)
Sanofi (France)
AbbVie Inc
Gilead Sciences, Inc
Roche, Ltd
Ingelheim GmbH
Janssen Pharmaceutical (Johnson & Johnson)

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Infectious Disease Therapeutics Market’s key players continually seek to stay ahead by offering new Disease Types and developments.

In March 2022, May & Baker Nigeria Plc introduced Artelum Combo, a novel medicine to combat malaria parasites across the country. The medication is a one-of-a-kind combination of Arthemeter Lumefantrine and Paracetamol that delivers comprehensive malaria treatment in a single dose.

In May 2021, Ivejaj, a new anti-parasitic medicine from Bajaj Healthcare, is now available for the treatment of COVID infections. The Drugs Controller General of India has given the business permission to manufacture and market the tablets.

In March 2022, Seres Therapeutics, Inc., a famous microbiome therapeutics business, announced that the FDA had accepted its biologics license application (BLA) for priority review. The application is for their investigational microbiome treatment SER-109, which is designed to treat recurrent Clostridium difficile infection (CDI).

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

Treatment costs are expected to limit market growth.

Market segmented by Disease Type, Route of Administration, Targated pathogens, End-User, Product Type, Infectious desiease Indication, Resaerch and Development Stage and region.
Respiratory Infections is the fastest growing sector
Late-stage is the second largest stakeholder group in the Infectious Disease Therapeutics Market
North America is leading market growth; the market is highly competitive with key players including Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K), F. Hoffmann-La Roche Ltd (Switzerland), Merck & Co. (U.S.), AstraZeneca (U.K) and Mylan N.V. (U.S.)

Future Outlook

Increasing research and development investment
Biotechnology and genomics advancements
Rising interest in tailored and precision medicines
An increase in the incidence of drug-resistant illnesses
Healthcare infrastructure expansion in emerging markets
Diagnostic tool technological breakthroughs
Industry collaborations and alliances
Emphasis on preventative measures and early diagnosis

Segmentation

By Disease Type:
- Antibiotics
- Antivirals
- Antifungals
- Antiparasitics
- Vaccines
By Route of Administration:
- Oral Drugs
- Intravenous (IV) Drugs
- Topical Drugs
- Inhalable Drugs
- Injectable Drugs
By Targeted Pathogens:
- Bacterial Infections
- Viral Infections
- Fungal Infections
- Parasitic Infections
By End-Users:
- Hospitals
- Clinics and Outpatient Centers
- Home Healthcare
- Pharmacies
By Product Type:
- Branded Drugs
- Generic Drugs
- Vaccines
By Infectious Disease Indications:
- Respiratory Infections
- Sexually Transmitted Infections (STIs)
- Vector-Borne Diseases
- Zoonotic Diseases
By Research and Development Stage:
- Early-stage
- Late-stage
- Marketed Products
By Region
- North America
  - U.S
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - U.K.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of Middle East and Africa

Adjacent Markets

In the Infectious Disease Therapeutics Market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Infectious Disease Therapeutics Market-

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

2. Executive Summary

2.1. Market Snapshot: Global Infectious Disease Therapeutics Market

2.1.1. Global Infectious Disease Therapeutics Market, By Disease Type

2.1.2. Global Infectious Disease Therapeutics Market, By Route of Administration

2.1.3. Global Infectious Disease Therapeutics Market, By Targeted Pathogens

2.1.4. Global Infectious Disease Therapeutics Market, By End-users

2.1.5. Global Infectious Disease Therapeutics Market, By Product Type

2.1.6. Global Infectious Disease Therapeutics Market, By Infectious Disease Indications

2.1.7. Global Infectious Disease Therapeutics Market, By Research and Development Stage

2.1.8. Global Infectious Disease Therapeutics Market, By Region

2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Infectious Disease Therapeutics Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Infectious Disease Therapeutics Market Drivers

3.2.2. Infectious Disease Therapeutics Market Restraints

3.2.3. Infectious Disease Therapeutics Market Opportunities

3.2.4. Major Infectious Disease Therapeutics Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Disease Type

3.5.2. Route of Administration

3.5.3. Targeted Pathogens

3.5.4. End-users

3.5.5. Product Type

3.5.6. Infectious Disease Indications

3.5.7. Research and Development Stage

3.5.8. Geography

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Infectious Disease Therapeutics Market: Company Market Share, Value 2022

4.1.2. Global Infectious Disease Therapeutics Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Infectious Disease Therapeutics Market: Top 3 Company Market Share, Value 2022

4.2. Global Infectious Disease Therapeutics Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Infectious Disease Therapeutics Market

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Infectious Disease Therapeutics Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

8. Global Infectious Disease Therapeutics Market, By Disease Type

8.1. Global Infectious Disease Therapeutics Market Overview, by Disease Type

8.1.1. Global Infectious Disease Therapeutics Market Revenue Share, By Disease Type, 2022 Vs 2030 (in %)

8.2. Antibiotics

8.2.1. Global Infectious Disease Therapeutics Market, By ANTIBIOTICS, By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for ANTIBIOTICS

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Antivirals

8.3.1. Global Infectious Disease Therapeutics Market, By ANTIVIRALS, By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for ANTIVIRALS

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

8.4. Antifungals

8.4.1. Global Infectious Disease Therapeutics Market, By Antifungals, By Region, 2017-2030 (US$ Mn)

8.4.2. Market Dynamics for Antifungals

8.4.2.1. Drivers

8.4.2.2. Restraints

8.4.2.3. Opportunities

8.4.2.4. Trends

8.5. Antiparasitics

8.5.1. Global Infectious Disease Therapeutics Market, By Antiparasitics, By Region, 2017-2030 (US$ Mn)

8.5.2. Market Dynamics for Antiparasitics

8.5.2.1. Drivers

8.5.2.2. Restraints

8.5.2.3. Opportunities

8.5.2.4. Trends

8.6. Vaccines

8.6.1. Global Infectious Disease Therapeutics Market, By Vaccines, By Region, 2017-2030 (US$ Mn)

8.6.2. Market Dynamics for Vaccines

8.6.2.1. Drivers

8.6.2.2. Restraints

8.6.2.3. Opportunities

8.6.2.4. Trends

9. Global Infectious Disease Therapeutics Market, By Route of Administrations

9.1. Global Infectious Disease Therapeutics Market Overview, by Route of Administrations

9.1.1. Global Infectious Disease Therapeutics Market Revenue Share, By Route of Administrations, 2022 Vs 2030 (in %)

9.2. Oral Drugs

9.2.1. Global Infectious Disease Therapeutics Market, By Oral Drugs, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Oral Drugs

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Intravenous (IV) Drugs

9.3.1. Global Infectious Disease Therapeutics Market, By Intravenous (IV) Drugs, By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Intravenous (IV) Drugs

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Topical Drugs

9.4.1. Global Infectious Disease Therapeutics Market, By Topical Drugs, By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Topical Drugs

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

10. Global Infectious Disease Therapeutics Market, By Targeted Pathogens

10.1. Global Infectious Disease Therapeutics Market Overview, by Targeted Pathogens

10.1.1. Global Infectious Disease Therapeutics Market Revenue Share, By Targeted Pathogens, 2022 Vs 2030 (in %)

10.2. Bacterial Infections

10.2.1. Global Infectious Disease Therapeutics Market, By Bacterial Infections, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Bacterial Infections

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Viral Infections

10.3.1. Global Infectious Disease Therapeutics Market, By Viral Infections, By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Viral Infections

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

11. Global Infectious Disease Therapeutics Market, By End-users

11.1. Global Infectious Disease Therapeutics Market Overview, by End-users

11.1.1. Global Infectious Disease Therapeutics Market Revenue Share, By End-users, 2022 Vs 2030 (in %)

11.2. Hospitals

11.2.1. Global Infectious Disease Therapeutics Market, By Hospitals, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Hospitals

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Clinics and Outpatient Centers

11.3.1. Global Infectious Disease Therapeutics Market, By Clinics and Outpatient Centers, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Clinics and Outpatient Centers

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

11.4. Home Healthcare

11.4.1. Global Infectious Disease Therapeutics Market, By Home Healthcare, By Region, 2017-2030 (US$ Mn)

11.4.2. Market Dynamics for Home Healthcare

11.4.2.1. Drivers

11.4.2.2. Restraints

11.4.2.3. Opportunities

11.4.2.4. Trends

12. Global Infectious Disease Therapeutics Market, By Product Type

12.1. Global Infectious Disease Therapeutics Market Overview, by Product Type

12.1.1. Global Infectious Disease Therapeutics Market Revenue Share, By Product Type, 2022 Vs 2030 (in %)

12.2. Branded Drugs

12.2.1. Global Infectious Disease Therapeutics Market, By Branded Drugs, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Branded Drugs

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Generic Drugs

12.3.1. Global Infectious Disease Therapeutics Market, By Generic Drugs, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for Generic Drugs

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

13. Global Infectious Disease Therapeutics Market, By Infectious Disease Indications

13.1. Global Infectious Disease Therapeutics Market Overview, by Infectious Disease Indications

13.1.1. Global Infectious Disease Therapeutics Market Revenue Share, By Infectious Disease Indications, 2022 Vs 2030 (in %)

13.2. Respiratory Infections

13.2.1. Global Infectious Disease Therapeutics Market, By Respiratory Infections, By Region, 2017-2030 (US$ Mn)

13.2.2. Market Dynamics for Respiratory Infections

13.2.2.1. Drivers

13.2.2.2. Restraints

13.2.2.3. Opportunities

13.2.2.4. Trends

13.3. Sexually Transmitted Infections (STIs)

13.3.1. Global Infectious Disease Therapeutics Market, By Sexually Transmitted Infections (STIs), By Region, 2017-2030 (US$ Mn)

13.3.2. Market Dynamics for Sexually Transmitted Infections (STIs)

13.3.2.1. Drivers

13.3.2.2. Restraints

13.3.2.3. Opportunities

13.3.2.4. Trends

13.4. Vector-Borne Diseases

13.4.1. Global Infectious Disease Therapeutics Market, By Vector-Borne Diseases, By Region, 2017-2030 (US$ Mn)

13.4.2. Market Dynamics for Vector-Borne Diseases

13.4.2.1. Drivers

13.4.2.2. Restraints

13.4.2.3. Opportunities

13.4.2.4. Trends

14. Global Infectious Disease Therapeutics Market, By Research and Development Stage

14.1. Global Infectious Disease Therapeutics Market Overview, by Research and Development Stage

14.1.1. Global Infectious Disease Therapeutics Market Revenue Share, By Research and Development Stage, 2022 Vs 2030 (in %)

14.2. Early-stage

14.2.1. Global Infectious Disease Therapeutics Market, By Early-stage, By Region, 2017-2030 (US$ Mn)

14.2.2. Market Dynamics for Early-stage

14.2.2.1. Drivers

14.2.2.2. Restraints

14.2.2.3. Opportunities

14.2.2.4. Trends

14.3. Late-stage

14.3.1. Global Infectious Disease Therapeutics Market, By Late-stage, By Region, 2017-2030 (US$ Mn)

14.3.2. Market Dynamics for Late-stage

14.3.2.1. Drivers

14.3.2.2. Restraints

14.3.2.3. Opportunities

14.3.2.4. Trends

15. Global Infectious Disease Therapeutics Market, By Region

15.1. Global Infectious Disease Therapeutics Market Overview, by Region

15.1.1. Global Infectious Disease Therapeutics Market, By Region, 2022 vs 2030 (in%)

15.2. Disease Type

15.2.1. Global Infectious Disease Therapeutics Market, By Disease Type, 2017-2030 (US$ Mn)

15.3. Route of Administration

15.3.1. Global Infectious Disease Therapeutics Market, By Route of Administration, 2017-2030 (US$ Mn)

15.4. Targeted Pathogens

15.4.1. Global Infectious Disease Therapeutics Market, By Targeted Pathogens, 2017-2030 (US$ Mn)

15.5. End-users

15.5.1. Global Infectious Disease Therapeutics Market, By End-users, 2017-2030 (US$ Mn)

15.6. Product Type

15.6.1. Global Infectious Disease Therapeutics Market, By Product Type, 2017-2030 (US$ Mn)

15.7. Infectious Disease Indications

15.7.1. Global Infectious Disease Therapeutics Market, By Infectious Disease Indications, 2017-2030 (US$ Mn)

15.8. Research and Development Stage

15.8.1. Global Infectious Disease Therapeutics Market, By Research and Development Stage, 2017-2030 (US$ Mn)

16. North America Infectious Disease Therapeutics Market Analysis

16.1. Overview

16.1.1. Market Dynamics for North America

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. North America Infectious Disease Therapeutics Market, by Disease Type, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. North America Infectious Disease Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. North America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. North America Infectious Disease Therapeutics Market, by End-users, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. North America Infectious Disease Therapeutics Market, by Product Type, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. North America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2030(US$ Mn)

16.7.1. Overview

16.7.2. SRC Analysis

16.8. North America Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2030(US$ Mn)

16.8.1. Overview

16.8.2. SRC Analysis

16.9. North America Infectious Disease Therapeutics Market, by Country, 2017-2030(US$ Mn)

16.9.1. North America Infectious Disease Therapeutics Market, by Country, 2022 Vs 2030 (in%)

16.9.2. U.S.

16.9.3. Canada

16.9.4. Mexico

17. Europe Infectious Disease Therapeutics Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Europe Infectious Disease Therapeutics Market, by Disease Type, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Europe Infectious Disease Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Europe Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Europe Infectious Disease Therapeutics Market, by End-users, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Europe Infectious Disease Therapeutics Market, by Product Type, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Europe Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2030(US$ Mn)

17.7.1. Overview

17.7.2. SRC Analysis

17.8. Europe Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2030(US$ Mn)

17.8.1. Overview

17.8.2. SRC Analysis

17.9. Europe Infectious Disease Therapeutics Market, by Country, 2017-2030 (US$ Mn)

17.9.1. Europe Infectious Disease Therapeutics Market, by Country, 2022 Vs 2030 (in%)

17.9.2. UK

17.9.3. France

17.9.4. Germany

17.9.5. Italy

17.9.6. Spain

17.9.7. Benelux

17.9.8. Russia

17.9.9. Rest of Europe

18. Asia Pacific Infectious Disease Therapeutics Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Asia Pacific Infectious Disease Therapeutics Market, by Disease Type, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Asia Pacific Infectious Disease Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Asia Pacific Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Asia Pacific Infectious Disease Therapeutics Market, by End-users, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Asia Pacific Infectious Disease Therapeutics Market, by Product Type, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Asia Pacific Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2030(US$ Mn)

18.7.1. Overview

18.7.2. SRC Analysis

18.8. Asia Pacific Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2030(US$ Mn)

18.8.1. Overview

18.8.2. SRC Analysis

18.9. Asia Pacific Infectious Disease Therapeutics Market, by Country, 2017-2030 (US$ Mn)

18.9.1. Asia Pacific Infectious Disease Therapeutics Market, by Country, 2022 Vs 2030 (in%)

18.9.2. China

18.9.3. Japan

18.9.4. India

18.9.5. South Korea

18.9.6. South East Asia

18.9.7. Rest of Asia Pacific

19. Latin America Infectious Disease Therapeutics Market Analysis

19.1. Overview

19.1.1. Market Dynamics for North America

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Latin America Infectious Disease Therapeutics Market, by Disease Type, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Latin America Infectious Disease Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Latin America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Latin America Infectious Disease Therapeutics Market, by End-users, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Latin America Infectious Disease Therapeutics Market, by Product Type, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Latin America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2030(US$ Mn)

19.7.1. Overview

19.7.2. SRC Analysis

19.8. Latin America Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2030(US$ Mn)

19.8.1. Overview

19.8.2. SRC Analysis

19.9. Latin America Infectious Disease Therapeutics Market, by Country, 2017-2030 (US$ Mn)

19.9.1. Latin America Infectious Disease Therapeutics Market, by Country, 2022 Vs 2030 (in%)

19.9.2. Brazil

19.9.3. Argentina

19.9.4. Rest of Latin America

20. Middle East Infectious Disease Therapeutics Market Analysis

20.1. Overview

20.1.1. Market Dynamics for North America

20.1.1.1. Drivers

20.1.1.2. Restraints

20.1.1.3. Opportunities

20.1.1.4. Trends

20.2. Middle East Infectious Disease Therapeutics Market, by Disease Type, 2017-2030(US$ Mn)

20.2.1. Overview

20.2.2. SRC Analysis

20.3. Middle East Infectious Disease Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

20.3.1. Overview

20.3.2. SRC Analysis

20.4. Middle East Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2030(US$ Mn)

20.4.1. Overview

20.4.2. SRC Analysis

20.5. Middle East Infectious Disease Therapeutics Market, by End-users, 2017-2030(US$ Mn)

20.5.1. Overview

20.5.2. SRC Analysis

20.6. Middle East Infectious Disease Therapeutics Market, by Product Type, 2017-2030(US$ Mn)

20.6.1. Overview

20.6.2. SRC Analysis

20.7. Middle East Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2030(US$ Mn)

20.7.1. Overview

20.7.2. SRC Analysis

20.8. Middle East Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2030(US$ Mn)

20.8.1. Overview

20.8.2. SRC Analysis

20.9. Middle East Infectious Disease Therapeutics Market, by Country, 2017-2030 (US$ Mn)

20.9.1. Middle East Infectious Disease Therapeutics Market, by Country, 2022 Vs 2030 (in%)

20.9.2. UAE

20.9.3. Saudi Arabia

20.9.4. Rest of Middle East

21. Africa Infectious Disease Therapeutics Market Analysis

21.1. Overview

21.1.1. Market Dynamics for North America

21.1.1.1. Drivers

21.1.1.2. Restraints

21.1.1.3. Opportunities

21.1.1.4. Trends

21.2. Africa Infectious Disease Therapeutics Market, by Disease Type, 2017-2030(US$ Mn)

21.2.1. Overview

21.2.2. SRC Analysis

21.3. Africa Infectious Disease Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

21.3.1. Overview

21.3.2. SRC Analysis

21.4. Africa Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2030(US$ Mn)

21.4.1. Overview

21.4.2. SRC Analysis

21.5. Africa Infectious Disease Therapeutics Market, by End-users, 2017-2030(US$ Mn)

21.5.1. Overview

21.5.2. SRC Analysis

21.6. Africa Infectious Disease Therapeutics Market, by Product Type, 2017-2030(US$ Mn)

21.6.1. Overview

21.6.2. SRC Analysis

21.7. Africa Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2030(US$ Mn)

21.7.1. Overview

21.7.2. SRC Analysis

21.8. Africa Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2030(US$ Mn)

21.8.1. Overview

21.8.2. SRC Analysis

21.9. Africa Infectious Disease Therapeutics Market, by Country, 2017-2030 (US$ Mn)

21.9.1. Middle East Infectious Disease Therapeutics Market, by Country, 2022 Vs 2030 (in%)

21.9.2. South Africa

21.9.3. Egypt

21.9.4. Rest of Africa

22. Company Profiles

22.1. Pfizer Inc. (U.S.)

22.1.1. Company Overview

22.1.2. Products/Services Portfolio

22.1.3. Geographical Presence

22.1.4. SWOT Analysis

22.1.5. Financial Summary

22.1.5.1. Market Revenue and Net Profit (2019-2022)

22.1.5.2. Business Segment Revenue Analysis

22.1.5.3. Geographical Revenue Analysis

22.2. GlaxoSmithKline plc. (U.K)

22.3. Merck & Co. (U.S.)

22.4. F. Hoffmann-La Roche Ltd (Switzerland)

22.5. AstraZeneca (U.K)

22.6. Mylan N.V. (U.S.)

22.7. Novartis AG (Switzerland)

22.8. Sanofi (France)

22.9. AbbVie Inc

22.10. Gilead Sciences, Inc

22.11. Roche, Ltd

22.12. Ingelheim GmbH

22.13. Janssen Pharmaceutical (Johnson & Johnson)

23. Research Methodology

23.1. Research Methodology

23.2. Phase I – Secondary Research

23.3. Phase II – Data Modelling

23.3.1. Company Share Analysis Model

23.3.2. Revenue Based Modelling

23.4. Phase III – Primary Research

23.5. Research Limitations

23.5.1. Assumptions

List of Figures

FIG. 1 Global Infectious Disease Therapeutics Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Infectious Disease Therapeutics Market Segmentation

FIG. 4 Global Infectious Disease Therapeutics Market, by Disease Type, 2022 (US$ Mn)

FIG. 5 Global Infectious Disease Therapeutics Market, by Route of Administration, 2022 (US$ Mn)

FIG. 6 Global Infectious Disease Therapeutics Market, by Targeted Pathogens, 2022 (US$ Mn)

FIG. 7 Global Infectious Disease Therapeutics Market, by Data Trasnfer Speed, 2022 (US$ Mn)

FIG. 8 Global Infectious Disease Therapeutics Market, by Product Type, 2022 (US$ Mn)

FIG. 9 Global Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2022 (US$ Mn)

FIG. 10 Global Infectious Disease Therapeutics Market, by Research and Development Stage, 2022 (US$ Mn)

FIG. 11 Global Infectious Disease Therapeutics Market, by Geography, 2022 (US$ Mn)

FIG. 12 Attractive Investment Proposition, by Disease Type, 2022

FIG. 13 Attractive Investment Proposition, by Route of Administration, 2022

FIG. 14 Attractive Investment Proposition, by Targeted Pathogens, 2022

FIG. 15 Attractive Investment Proposition, by End-users, 2022

FIG. 16 Attractive Investment Proposition, by Product Type, 2022

FIG. 17 Attractive Investment Proposition, by Infectious Disease Indications, 2022

FIG. 18 Attractive Investment Proposition, by Research and Development Stage, 2022

FIG. 19 Attractive Investment Proposition, by Geography, 2022

FIG. 20 Global Market Share Analysis of Key Infectious Disease Therapeutics Market Manufacturers, 2022

FIG. 21 Global Market Positioning of Key Infectious Disease Therapeutics Market Manufacturers, 2022

FIG. 22 Global Infectious Disease Therapeutics Market Value Contribution, By Disease Type, 2022 & 2030 (Value %)

FIG. 23 Global Infectious Disease Therapeutics Market, by ANTIBIOTICS, Value, 2017-2030 (US$ Mn)

FIG. 24 Global Infectious Disease Therapeutics Market, by ANTIVIRALS, Value, 2017-2030 (US$ Mn)

FIG. 25 Global Infectious Disease Therapeutics Market, by Antifungals, Value, 2017-2030 (US$ Mn)

FIG. 26 Global Infectious Disease Therapeutics Market, by Antiparasitics, Value, 2017-2030 (US$ Mn)

FIG. 27 Global Infectious Disease Therapeutics Market, by Vaccines, Value, 2017-2030 (US$ Mn)

FIG. 28 Global Infectious Disease Therapeutics Market Value Contribution, By Route of Administration, 2022 & 2030 (Value %)

FIG. 29 Global Infectious Disease Therapeutics Market, by Oral Drugs, Value, 2017-2030 (US$ Mn)

FIG. 30 Global Infectious Disease Therapeutics Market, by Intravenous (IV) Drugs, Value, 2017-2030 (US$ Mn)

FIG. 31 Global Infectious Disease Therapeutics Market, by Topical Drugs, Value, 2017-2030 (US$ Mn)

FIG. 32 Global Infectious Disease Therapeutics Market Value Contribution, By Targeted Pathogens, 2022 & 2030 (Value %)

FIG. 33 Global Infectious Disease Therapeutics Market, by Bacterial Infections, Value, 2017-2030 (US$ Mn)

FIG. 34 Global Infectious Disease Therapeutics Market, by Viral Infections, Value, 2017-2030 (US$ Mn)

FIG. 35 Global Infectious Disease Therapeutics Market Value Contribution, By End-users, 2022 & 2030 (Value %)

FIG. 36 Global Infectious Disease Therapeutics Market, by Hospitals, Value, 2017-2030 (US$ Mn)

FIG. 37 Global Infectious Disease Therapeutics Market, by Clinics and Outpatient Centers, Value, 2017-2030 (US$ Mn)

FIG. 38 Global Infectious Disease Therapeutics Market, by Home Healthcare, Value, 2017-2030 (US$ Mn)

FIG. 39 Global Infectious Disease Therapeutics Market Value Contribution, By Product Type, 2022 & 2030 (Value %)

FIG. 40 Global Infectious Disease Therapeutics Market, by Branded Drugs, Value, 2017-2030 (US$ Mn)

FIG. 41 Global Infectious Disease Therapeutics Market, by Generic Drugs, Value, 2017-2030 (US$ Mn)

FIG. 42 Global Infectious Disease Therapeutics Market Value Contribution, By Infectious Disease Indications, 2022 & 2030 (Value %)

FIG. 43 Global Infectious Disease Therapeutics Market, by Respiratory Infections, Value, 2017-2030 (US$ Mn)

FIG. 44 Global Infectious Disease Therapeutics Market, by Sexually Transmitted Infections (STIs), Value, 2017-2030 (US$ Mn)

FIG. 45 Global Infectious Disease Therapeutics Market, by Vector-Borne Diseases, Value, 2017-2030 (US$ Mn)

FIG. 46 Global Infectious Disease Therapeutics Market, by Specialty Stores, Value, 2017-2030 (US$ Mn)

FIG. 47 Global Infectious Disease Therapeutics Market Value Contribution, By Research and Development Stage, 2022 & 2030 (Value %)

FIG. 48 Global Infectious Disease Therapeutics Market, by Early-stage, Value, 2017-2030 (US$ Mn)

FIG. 49 Global Infectious Disease Therapeutics Market, by Late-stage, Value, 2017-2030 (US$ Mn)

FIG. 50 North America Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 51 U.S. Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 52 Canada Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 53 Mexico Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 54 Europe Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 55 Germany Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 56 France Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 57 U.K. Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 58 Italy Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 59 Spain Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 60 Benelux Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 61 Russia Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 62 Rest of Europe Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 63 Asia Pacific Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 64 China Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 65 Japan Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 66 India Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 67 South Korea Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 68 South-East Asia Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 69 Rest of Asia Pacific Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 70 Latin America Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 71 Brazil Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 72 Argentina Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 73 Rest of Latin America Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 74 Middle East Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 75 UAE Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 76 Saudi Arabia Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 77 Rest of Middle East Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 78 Africa Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 79 South Africa Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 80 Egypt Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 81 Rest of Africa Infectious Disease Therapeutics Market, 2017-2030 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Infectious Disease Therapeutics Market

TABLE 2 Global Infectious Disease Therapeutics Market: Market Drivers Impact Analysis

TABLE 3 Global Infectious Disease Therapeutics Market: Market Restraints Impact Analysis

TABLE 4 Global Infectious Disease Therapeutics Market, by Competitive Benchmarking, 2022

TABLE 5 Global Infectious Disease Therapeutics Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Infectious Disease Therapeutics Market, by Key Strategies Analysis, 2022

TABLE 7 Global Infectious Disease Therapeutics Market, by ANTIBIOTICS, By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Infectious Disease Therapeutics Market, by ANTIBIOTICS, By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Infectious Disease Therapeutics Market, by ANTIVIRALS, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Infectious Disease Therapeutics Market, by ANTIVIRALS, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Infectious Disease Therapeutics Market, by Antifungals, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Infectious Disease Therapeutics Market, by Antifungals, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Infectious Disease Therapeutics Market, by Antiparasitics, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Infectious Disease Therapeutics Market, by Antiparasitics, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Infectious Disease Therapeutics Market, by Vaccines, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Infectious Disease Therapeutics Market, by Vaccines, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Infectious Disease Therapeutics Market, by Oral Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Infectious Disease Therapeutics Market, by Oral Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Infectious Disease Therapeutics Market, by Intravenous (IV) Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Infectious Disease Therapeutics Market, by Intravenous (IV) Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Infectious Disease Therapeutics Market, by Topical Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Infectious Disease Therapeutics Market, by Topical Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Infectious Disease Therapeutics Market, by Bacterial Infections, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Infectious Disease Therapeutics Market, by Bacterial Infections, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Infectious Disease Therapeutics Market, by Viral Infections, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Infectious Disease Therapeutics Market, by Viral Infections, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Infectious Disease Therapeutics Market, by Hospitals, By Region, 2017-2022 (US$ Mn)

TABLE 28 Global Infectious Disease Therapeutics Market, by Hospitals, By Region, 2023-2030 (US$ Mn)

TABLE 29 Global Infectious Disease Therapeutics Market, by Clinics and Outpatient Centers, By Region, 2017-2022 (US$ Mn)

TABLE 30 Global Infectious Disease Therapeutics Market, by Clinics and Outpatient Centers, By Region, 2023-2030 (US$ Mn)

TABLE 31 Global Infectious Disease Therapeutics Market, by Home Healthcare, By Region, 2017-2022 (US$ Mn)

TABLE 32 Global Infectious Disease Therapeutics Market, by Home Healthcare, By Region, 2023-2030 (US$ Mn)

TABLE 33 Global Infectious Disease Therapeutics Market, by Branded Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 34 Global Infectious Disease Therapeutics Market, by Branded Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 35 Global Infectious Disease Therapeutics Market, by Generic Drugs, By Region, 2023-2030 (US$ Mn)

TABLE 36 Global Infectious Disease Therapeutics Market, by Generic Drugs, By Region, 2017-2022 (US$ Mn)

TABLE 37 Global Infectious Disease Therapeutics Market, by Respiratory Infections, By Region, 2017-2022 (US$ Mn)

TABLE 38 Global Infectious Disease Therapeutics Market, by Respiratory Infections, By Region, 2023-2030 (US$ Mn)

TABLE 39 Global Infectious Disease Therapeutics Market, by Sexually Transmitted Infections (STIs), By Region, 2017-2022 (US$ Mn)

TABLE 40 Global Infectious Disease Therapeutics Market, by Sexually Transmitted Infections (STIs), By Region, 2023-2030 (US$ Mn)

TABLE 41 Global Infectious Disease Therapeutics Market, by Vector-Borne Diseases, By Region, 2017-2022 (US$ Mn)

TABLE 42 Global Infectious Disease Therapeutics Market, by Vector-Borne Diseases, By Region, 2023-2030 (US$ Mn)

TABLE 43 Global Infectious Disease Therapeutics Market, by Early-stage, By Region, 2017-2022 (US$ Mn)

TABLE 44 Global Infectious Disease Therapeutics Market, by Early-stage, By Region, 2023-2030 (US$ Mn)

TABLE 45 Global Infectious Disease Therapeutics Market, by Late-stage, By Region, 2017-2022 (US$ Mn)

TABLE 46 Global Infectious Disease Therapeutics Market, by Late-stage, By Region, 2023-2030 (US$ Mn)

TABLE 47 Global Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 48 Global Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 49 Global Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 50 Global Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 51 Global Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 52 Global Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 53 Global Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 54 Global Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 55 Global Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 56 Global Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 57 Global Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 58 Global Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 59 Global Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 60 Global Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 61 Global Infectious Disease Therapeutics Market, by Region, 2017-2022 (US$ Mn)

TABLE 62 Global Infectious Disease Therapeutics Market, by Region, 2023-2030 (US$ Mn)

TABLE 63 North America Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 64 North America Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 65 North America Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 66 North America Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 67 North America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 68 North America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 69 North America Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 70 North America Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 71 North America Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 72 North America Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 73 North America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 74 North America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 75 North America Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 76 North America Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 77 North America Infectious Disease Therapeutics Market, by Country, 2017-2022 (US$ Mn)

TABLE 78 North America Infectious Disease Therapeutics Market, by Country, 2023-2030 (US$ Mn)

TABLE 79 United States Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 80 United States Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 81 United States Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 82 United States Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 83 United States Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 84 United States Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 85 United States Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 86 United States Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 87 United States Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 88 United States Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 89 United States Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 90 United States Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 91 United States Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 92 United States Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 93 Canada Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 94 Canada Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 95 Canada Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 96 Canada Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 97 Canada Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 98 Canada Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 99 Canada Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 100 Canada Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 101 Canada Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 102 Canada Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 103 Canada Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 104 Canada Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 105 Canada Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 106 Canada Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 107 Mexico Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 108 Mexico Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 109 Mexico Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 110 Mexico Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 111 Mexico Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 112 Mexico Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 113 Mexico Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 114 Mexico Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 115 Mexico Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 116 Mexico Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 117 Mexico Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 118 Mexico Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 119 MexicoInfectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 120 MexicoInfectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 121 Europe Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 122 Europe Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 123 Europe Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 124 Europe Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 125 Europe Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 126 Europe Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 127 Europe Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 128 Europe Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 129 Europe Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 130 Europe Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 131 Europe Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 132 Europe Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 133 Europe Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 134 Europe Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 135 Europe Infectious Disease Therapeutics Market, by Country, 2017-2022 (US$ Mn)

TABLE 136 Europe Infectious Disease Therapeutics Market, by Country, 2023-2030 (US$ Mn)

TABLE 137 Germany Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 138 Germany Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 139 Germany Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 140 Germany Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 141 Germany Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 142 Germany Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 143 Germany Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 144 Germany Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 145 Germany Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 146 Germany Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 147 Germany Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 148 Germany Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 149 Germany Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 150 Germany Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 151 France Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 152 France Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 153 France Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 154 France Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 155 France Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 156 France Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 157 France Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 158 France Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 159 France Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 160 France Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 161 France Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 162 France Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 163 France Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 164 France Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 165 United Kingdom Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 166 United Kingdom Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 167 United Kingdom Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 168 United Kingdom Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 169 United Kingdom Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 170 United Kingdom Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 171 United Kingdom Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 172 United Kingdom Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 173 United Kingdom Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 174 United Kingdom Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 175 United Kingdom Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 176 United Kingdom Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 177 United Kingdom Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 178 United Kingdom Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 179 Italy Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 180 Italy Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 181 Italy Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 182 Italy Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 183 Italy Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 184 Italy Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 185 Italy Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 186 Italy Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 187 Italy Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 188 Italy Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 189 Italy Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 190 Italy Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 191 Italy Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 192 Italy Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 193 Spain Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 194 Spain Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 195 Spain Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 196 Spain Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 197 Spain Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 198 Spain Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 199 Spain Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 200 Spain Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 201 Spain Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 202 Spain Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 203 Spain Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 204 Spain Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 205 Spain Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 206 Spain Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 207 Benelux Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 208 Benelux Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 209 Benelux Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 210 Benelux Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 211 Benelux Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 212 Benelux Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 213 Benelux Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 214 Benelux Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 215 Benelux Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 216 Benelux Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 217 Benelux Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 218 Benelux Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 219 Benelux Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 220 Benelux Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 221 Russia Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 222 Russia Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 223 Russia Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 224 Russia Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 225 Russia Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 226 Russia Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 227 Russia Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 228 Russia Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 229 Russia Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 230 Russia Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 231 Russia Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 232 Russia Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 233 Russia Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 234 Russia Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 235 Rest of Europe Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 236 Rest of Europe Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 237 Rest of Europe Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 238 Rest of Europe Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 239 Rest of Europe Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 240 Rest of Europe Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 241 Rest of Europe Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 242 Rest of Europe Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 243 Rest of Europe Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 244 Rest of Europe Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 245 Rest of Europe Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 246 Rest of Europe Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 247 Rest of Europe Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 248 Rest of Europe Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 249 Asia Pacific Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 250 Asia Pacific Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 251 Asia Pacific Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 252 Asia Pacific Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 253 Asia Pacific Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 254 Asia Pacific Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 255 Asia Pacific Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 256 Asia Pacific Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 257 Asia Pacific Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 258 Asia Pacific Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 259 Asia Pacific Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 260 Asia Pacific Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 261 Asia Pacific Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 262 Asia Pacific Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 263 China Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 264 China Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 265 China Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 266 China Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 267 China Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 268 China Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 269 China Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 270 China Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 271 China Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 272 China Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 273 China Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 274 China Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 275 China Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 276 China Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 277 Japan Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 278 Japan Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 279 Japan Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 280 Japan Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 281 Japan Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 282 Japan Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 283 Japan Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 284 Japan Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 285 Japan Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 286 Japan Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 287 Japan Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 288 Japan Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 289 Japan Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 290 Japan Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 291 India Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 292 India Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 293 India Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 294 India Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 295 India Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 296 India Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 297 India Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 298 India Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 299 India Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 300 India Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 301 India Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 302 India Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 303 India Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 304 India Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 305 South Korea Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 306 South Korea Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 307 South Korea Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 308 South Korea Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 309 South Korea Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 310 South Korea Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 311 South Korea Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 312 South Korea Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 313 South Korea Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 314 South Korea Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 315 South Korea Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 316 South Korea Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 317 South Korea Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 318 South Korea Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 319 South-East Asia Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 320 South-East Asia Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 321 South-East Asia Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 322 South-East Asia Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 323 South-East Asia Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 324 South-East Asia Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 325 South-East Asia Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 326 South-East Asia Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 327 South-East Asia Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 328 South-East Asia Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 329 South-East Asia Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 330 South-East Asia Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 331 South-East Asia Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 332 South-East Asia Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 333 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 334 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 335 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 336 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 337 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 338 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 339 Rest of Asia Pacific Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 340 Rest of Asia Pacific Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 341 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 342 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 343 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 344 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 345 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 346 Rest of Asia Pacific Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 347 Latin America Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 348 Latin America Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 349 Latin America Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 350 Latin America Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 351 Latin America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 352 Latin America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 353 Latin America Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 354 Latin America Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 355 Latin America Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 356 Latin America Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 357 Latin America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 358 Latin America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 359 Latin America Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 360 Latin America Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 361 Brazil Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 362 Brazil Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 363 Brazil Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 364 Brazil Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 365 Brazil Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 366 Brazil Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 367 Brazil Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 368 Brazil Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 369 Brazil Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 370 Brazil Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 371 Brazil Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 372 Brazil Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 373 Brazil Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 374 Brazil Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 375 Argentina Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 376 Argentina Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 377 Argentina Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 378 Argentina Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 379 Argentina Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 380 Argentina Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 381 Argentina Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 382 Argentina Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 383 Argentina Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 384 Argentina Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 385 Argentina Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 386 Argentina Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 387 Argentina Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 388 Argentina Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 389 Rest of Latin America Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 390 Rest of Latin America Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 391 Rest of Latin America Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 392 Rest of Latin America Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 393 Rest of Latin America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 394 Rest of Latin America Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 395 Rest of Latin America Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 396 Rest of Latin America Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 397 Rest of Latin America Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 398 Rest of Latin America Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 399 Rest of Latin America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 400 Rest of Latin America Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 401 Rest of Latin America Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 402 Rest of Latin America Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 403 Middle East Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 404 Middle East Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 405 Middle East Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 406 Middle East Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 407 Middle East Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 408 Middle East Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 409 Middle East Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 410 Middle East Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 411 Middle East Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 412 Middle East Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 413 Middle East Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 414 Middle East Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 415 Middle East Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 416 Middle East Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 417 UAE Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 418 UAE Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 419 UAE Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 420 UAE Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 421 UAE Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 422 UAE Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 423 UAE Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 424 UAE Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 425 UAE Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 426 UAE Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 427 UAE Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 428 UAE Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 429 UAE Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 430 UAE Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 431 Saudi Arabia Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 432 Saudi Arabia Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 433 Saudi Arabia Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 434 Saudi Arabia Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 435 Saudi Arabia Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 436 Saudi Arabia Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 437 Saudi Arabia Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 438 Saudi Arabia Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 439 Saudi Arabia Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 440 Saudi Arabia Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 441 Saudi Arabia Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 442 Saudi Arabia Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 443 Saudi Arabia Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 444 Saudi Arabia Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 445 Rest of Middle East Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 446 Rest of Middle East Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 447 Rest of Middle East Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 448 Rest of Middle East Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 449 Rest of Middle East Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 450 Rest of Middle East Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 451 Rest of Middle East Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 452 Rest of Middle East Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 453 Rest of Middle East Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 454 Rest of Middle East Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 455 Rest of Middle East Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 456 Rest of Middle East Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 457 Rest of Middle East Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 458 Rest of Middle East Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 459 Africa Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 460 Africa Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 461 Africa Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 462 Africa Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 463 Africa Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 464 Africa Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 465 Africa Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 466 Africa Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 467 Africa Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 468 AfricaInfectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 469 Africa Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 470 Africa Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 471 Africa Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 472 Africa Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 473 South Africa Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 474 South Africa Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 475 South Africa Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 476 South Africa Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 477 South Africa Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 478 South Africa Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 479 South Africa Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 480 South Africa Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 481 South Africa Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 482 South Africa Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 483 South Africa Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 484 South Africa Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 485 South Africa Infectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 486 South Africa Infectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 487 Egypt Infectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 488 Egypt Infectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 489 Egypt Infectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 490 Egypt Infectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 491 Egypt Infectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 492 Egypt Infectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 493 Egypt Infectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 494 Egypt Infectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 495 Egypt Infectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 496 Egypt Infectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 497 Egypt Infectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 498 EgyptInfectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 499 EgyptInfectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 500 EgyptInfectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

TABLE 501 Rest of AfricaInfectious Disease Therapeutics Market, by Disease Type, 2017-2022 (US$ Mn)

TABLE 502 Rest of AfricaInfectious Disease Therapeutics Market, by Disease Type, 2023-2030 (US$ Mn)

TABLE 503 Rest of AfricaInfectious Disease Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 504 Rest of AfricaInfectious Disease Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 505 Rest of AfricaInfectious Disease Therapeutics Market, by Targeted Pathogens, 2017-2022 (US$ Mn)

TABLE 506 Rest of AfricaInfectious Disease Therapeutics Market, by Targeted Pathogens, 2023-2030 (US$ Mn)

TABLE 507 Rest of AfricaInfectious Disease Therapeutics Market, by End-users, By Region, 2017-2022 (US$ Mn)

TABLE 508 Rest of AfricaInfectious Disease Therapeutics Market, by End-users, By Region, 2023-2030 (US$ Mn)

TABLE 509 Rest of AfricaInfectious Disease Therapeutics Market, by Product Type, 2017-2022 (US$ Mn)

TABLE 510 Rest of AfricaInfectious Disease Therapeutics Market, by Product Type, 2023-2030 (US$ Mn)

TABLE 511 Rest of AfricaInfectious Disease Therapeutics Market, by Infectious Disease Indications, 2017-2022 (US$ Mn)

TABLE 512 Rest of AfricaInfectious Disease Therapeutics Market, by Infectious Disease Indications, 2023-2030 (US$ Mn)

TABLE 513 Rest of AfricaInfectious Disease Therapeutics Market, by Research and Development Stage, 2017-2022 (US$ Mn)

TABLE 514 Rest of AfricaInfectious Disease Therapeutics Market, by Research and Development Stage, 2023-2030 (US$ Mn)

Frequently asked questions

What is the current size of the worldwide Infectious Disease Therapeutics Market?

In 2022, the global Infectious Disease Therapeutics Market is expected to be worth USD 115845.9 million.

What is the predicted growth rate of the Infectious Disease Therapeutics Market between 2023 and 2030?

The Infectious Disease Therapeutics Market is estimated to increase at a CAGR of 5.00% between 2023 and 2030, reaching USD 171157.1 Million in 2030.

Which segment has the most market share in terms of end-users?

The hospital segment had the biggest revenue share of 54.5% in 2022

Which research and development stage segment governs the market demand for Infectious Disease Therapeutics ?

Marketed Products has the biggest market demand in the Infectious Disease Therapeutics Market

Which end-users segment is the fastest growing segment in the market over the forecast period?

The clinics and outpatient centers segment is predicted to grow at the fastest CAGR.

Which region is driving the Infectious Disease Therapeutics industry forward?

North America was the market leader in 2022, accounting for 39.9% of total revenue.

Who are the major players in the global Infectious Disease Therapeutics Market?

The top players include Pfizer Inc. (U.S.), Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), Merck & Co. (U.S.), F. Hoffmann-La AstraZeneca (U.K) and Mylan N.V. (U.S.).

What are the major market drivers of the Infectious Disease Therapeutics industry?

What are the major market restraints of the Infectious Disease Therapeutics industry?

The high expense of developing and producing novel treatments The market faces obstacles such as stringent regulatory standards and licensing processes, as well as the issue of tackling a varied variety of infectious diseases with varying treatment techniques.

What are the major market opportunities of the Infectious Disease Therapeutics industry?

Biotechnology and genetics advancements for tailored and precise medicines, Increasing research and development investments and Collaborations between pharmaceutical corporations and academic institutions for field innovation are a business opportunity.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –